HomeTeamDr. Garry Mccleane

Portrait of Dr. Garry Mccleane

Scientific Advisory Board

Dr. Garry Mccleane

Overview

Dr Gary McCleane, MD, is a consultant in Pain Management with a particular interest in neuropathic pain, topical analgesics, novel options for Pain Management and he has a particular interest in Cholecystokinin antagonists. He has had over 70 papers published and has had 26 chapters on pain related topics included in a variety of text books. McCleane is the clinical leader on Merck’s L-365,260 and proglumide, which was marketed under the brand Milid.

Collaborate with the team.

For research collaboration, clinical development, licensing, partnership or scientific advisory enquiries, contact the team.

Get in touch